GMP Storage Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The global GMP storage market size is likely to be valued at US$ 7.1 Bn in 2025 and is estimated to reach US$ 11.2 Bn by 2032, growing at a CAGR of 6.73% during the forecast period 2025–2032.

Market Insights

The GMP (Good Manufacturing Practice) storage market plays a vital role in safeguarding the quality, integrity, and compliance of biologics, cell and gene therapies, pharmaceuticals, and other life science products. GMP storage ensures temperature-controlled, contamination-free, and regulatory-compliant conditions critical to clinical research, drug development, and large-scale biomanufacturing. The rising demand for biopharmaceuticals, coupled with strict regulatory standards across the U.S., Europe, and Asia, is driving significant adoption of GMP-certified storage solutions worldwide.

GMP Storage Market – Report Scope

The GMP storage market encompasses products and services designed to meet regulatory standards for the secure handling and preservation of highly sensitive materials, including cell banks, gene therapies, and biologics. The scope includes refrigerators, freezers, cryogenic storage systems, as well as service offerings for GMP-compliant warehousing, monitoring, and quality assurance. Growing demand for cold-chain logistics, advancements in regenerative medicine, and the increasing complexity of drug pipelines are boosting market expansion across pharma, biotech, and research institutes.

Market Growth Drivers

Several factors are propelling growth in the GMP storage market. The expansion of the biopharmaceutical industry, driven by rising demand for monoclonal antibodies, vaccines, and gene therapies, is creating strong demand for compliant storage. Regulatory authorities such as the FDA and EMA enforce stringent standards for safe drug preservation, prompting pharma and biotech companies to invest in GMP-compliant infrastructure. Furthermore, growing clinical trial activity worldwide, coupled with increased outsourcing to contract manufacturing and research organizations, supports higher adoption of GMP-certified facilities and services.

Market Restraints

Despite strong growth prospects, the market faces challenges. High capital investment in GMP storage facilities and advanced cryogenic systems remains a barrier for small and mid-sized enterprises. Operating costs, including quality monitoring, validation, and compliance audits, further increase expenses. The complexity of maintaining regulatory approval across multiple jurisdictions can slow adoption. Additionally, the reliance on energy-intensive refrigeration and cryogenic systems raises sustainability concerns, limiting widespread deployment in regions with inadequate infrastructure and inconsistent energy supply.

Market Opportunities

The GMP storage market presents vast opportunities fueled by global investment in cell and gene therapies, personalized medicine, and regenerative healthcare. Increasing adoption of cloud-connected monitoring, IoT-enabled freezers, and AI-driven inventory tracking will enhance storage reliability and operational efficiency. Emerging markets such as Asia Pacific and Latin America offer untapped growth potential as biopharma production scales up in these regions. Expansion of outsourcing models, including GMP storage-as-a-service, provides a lucrative avenue for providers to cater to research institutions and mid-tier biotechs without extensive in-house facilities.

Regional Outlook
• North America dominates the GMP storage market, led by the U.S., where a strong biopharmaceutical base, extensive clinical research activity, and strict FDA guidelines drive adoption.
• Europe holds a significant share, supported by EMA regulatory enforcement and advanced biotech clusters in Germany, the UK, and France.
• Asia Pacific is projected to record the fastest growth, fueled by the expansion of pharmaceutical manufacturing in China and India, along with government initiatives in precision medicine and biologics production.
• Latin America and Middle East & Africa represent emerging markets where increasing healthcare investments and growing research capabilities will accelerate demand for GMP-compliant facilities.

Leading Companies

Key companies in the global GMP storage market are focusing on expanding their product portfolios and service capabilities to ensure compliance and reliability. Strategic partnerships, facility expansions, and investment in digital monitoring technologies are central to maintaining competitiveness.

Companies Covered in This Report:
• ThermoGenesis Holdings, Inc.
• ThermoFisher Scientific Inc.
• BioLife Solutions, Inc.
• Danaher (Cytiva)
• MEDIPOST
• REMI GROUP
• Eurofins Scientific
• Eppendorf
• Intertek Group Plc
• Arctiko
• Bioline Technologies
• Hindustan Apparatus Mfg. Co.
• P L Tandon & Co.
• Stericox India Private Limited
• SY-LAB Geräte GmbH
• BioConvergence LLC d/b/a Singota Solutions
• PHC Holdings Corporation
• Pace Life Sciences
• Haier Biomedical
• Helmer Scientific Inc.

Market Segmentation

By Product & Service:
• GMP Storage Products
Refrigerators and Freezers
Cryogenic Storage
• GMP Storage Services

By Application:
• Cell & Gene Therapy
• Cell Banking
• Biologics
• Small Molecules
• Others

By End User:
• Biopharmaceutical Companies
• Contract Manufacturing Organizations
• Contract Research Organizations
• Research & Academic Institutes

By Region:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Please note: Delivery Timelines - 5 working days. Show more